A dual-acting STAT5 inhibitor in the treatment of type 1 diabetes.
Abstract
This STAT5 inhibitor both protects against cytokine-induced beta-cell death and stimulates insulin secretion from islets.
Keywords:
Biological Sciences, type 1 diabetes mellitus, islets of Langerhans, inflammation, insulin-secreting beta-cells
Status
Undergraduate
Department
Biological Sciences
College
Honors Tutorial College
Campus
Athens
Faculty Mentor
Nunemaker, Craig
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
COinS
A dual-acting STAT5 inhibitor in the treatment of type 1 diabetes.
This STAT5 inhibitor both protects against cytokine-induced beta-cell death and stimulates insulin secretion from islets.